GNCA - Genocea Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

with an average price target of $30.91. This is a potential upside of $30.91 (0%) from yesterday's end of day stock price of $0.

Genocea Biosciences's activity chart (see below) currently has 32 price targets and 32 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 32.1 days.

Most recent stock forecast was given by STEPHEN WILLEY from STIFEL on 29-Apr-2022. First documented stock forecast 05-Mar-2014.

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold

Since 29-Apr-2022

3 years 8 months 25 days ago
(29-Apr-2022)

0/2 (0%)

$10 (100.00%)

Hold

Since 29-Apr-2022

$0.16

$0.16 (0.00%)

$18

3 years 8 months 25 days ago
(29-Apr-2022)

1/3 (33.33%)

$-0.12 (-42.86%)

25

Hold

Since 29-Apr-2022

$9

3 years 8 months 25 days ago
(29-Apr-2022)

1/2 (50%)

$5.4 (150.00%)

4

Buy

Since 01-Mar-2019

4 years 11 months 12 days ago
(11-Feb-2021)

0/1 (0%)

$9.91 (162.73%)

Buy

Since 03-Jun-2019

$8

$8 (0.00%)

$15

5 years 5 months 24 days ago
(30-Jul-2020)

0/2 (0%)

$4.55 (131.88%)

Show more analysts

Please expand the browser size to see the chart

What is GNCA (Genocea Biosciences) average time for price targets to be met?

On average it took 32.1 days on average for the stock forecasts to be realized with a an average price target met ratio 16.67

Which analyst has the current highest performing score on GNCA (Genocea Biosciences) with a proven track record?

EDWARD TENTHOFF

Which analyst has the most public recommendations on GNCA (Genocea Biosciences)?

Edward Tenthoff works at PIPER SANDLER and has 5 price targets and 5 ratings on GNCA

Which analyst is the currently most bullish on GNCA (Genocea Biosciences)?

Christopher James with highest potential upside - $136

Which analyst is the currently most reserved on GNCA (Genocea Biosciences)?

Chad Messer with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?